240 related articles for article (PubMed ID: 22280228)
21. Clinical characteristics and prognosis of familial nonmedullary thyroid carcinoma.
de Carlos Artajo J; Irigaray Echarri A; García Torres J; Pineda Arribas JJ; Ernaga Lorea A; Eguílaz Esparza N; Zubiría Gortázar JM; Anda Apiñániz E
Endocrinol Diabetes Nutr (Engl Ed); 2021 Sep; ():. PubMed ID: 34503933
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer.
Vriens MR; Suh I; Moses W; Kebebew E
Thyroid; 2009 Dec; 19(12):1343-9. PubMed ID: 20001717
[TBL] [Abstract][Full Text] [Related]
23. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F
Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282
[TBL] [Abstract][Full Text] [Related]
24. Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients.
Capezzone M; Sagnella A; Cantara S; Fralassi N; Maino F; Forleo R; Brilli L; Pilli T; Cartocci A; Castagna MG
Front Endocrinol (Lausanne); 2022; 13():845954. PubMed ID: 35311228
[TBL] [Abstract][Full Text] [Related]
25. Familial nonmedullary thyroid cancer: a review of the genetics.
Khan A; Smellie J; Nutting C; Harrington K; Newbold K
Thyroid; 2010 Jul; 20(7):795-801. PubMed ID: 20465534
[TBL] [Abstract][Full Text] [Related]
26. Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation.
Hillenbrand A; Varhaug JE; Brauckhoff M; Pandev R; Haufe S; Dotzenrath C; Köberle R; Hoffmann R; Klein G; Kadmon M; Negele T; Hagieva T; Henne-Bruns D; Luster M; Weber T
Langenbecks Arch Surg; 2010 Sep; 395(7):851-8. PubMed ID: 20683623
[TBL] [Abstract][Full Text] [Related]
27. Clinical behavior and genetics of nonsyndromic, familial nonmedullary thyroid cancer.
Bauer AJ
Front Horm Res; 2013; 41():141-8. PubMed ID: 23652675
[TBL] [Abstract][Full Text] [Related]
28. Familial nonmedullary thyroid carcinoma.
Malchoff CD; Malchoff DM
Semin Surg Oncol; 1999; 16(1):16-8. PubMed ID: 9890735
[TBL] [Abstract][Full Text] [Related]
29. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.
Alsanea O; Wada N; Ain K; Wong M; Taylor K; Ituarte PH; Treseler PA; Weier HU; Freimer N; Siperstein AE; Duh QY; Takami H; Clark OH
Surgery; 2000 Dec; 128(6):1043-50;discussion 1050-1. PubMed ID: 11114641
[TBL] [Abstract][Full Text] [Related]
30. Familial nonmedullary thyroid cancer: screening, clinical, molecular and genetic findings.
Navas-Carrillo D; Ríos A; Rodríguez JM; Parrilla P; Orenes-Piñero E
Biochim Biophys Acta; 2014 Dec; 1846(2):468-76. PubMed ID: 25218916
[TBL] [Abstract][Full Text] [Related]
31. FAMILIAL NON-MEDULLARY THYROID CARCINOMA.
Guda BB; Komisarenko II; Ostafiichuk MV; Tronko MD
Exp Oncol; 2023 Jun; 45(1):70-78. PubMed ID: 37417280
[TBL] [Abstract][Full Text] [Related]
32. Familial Nonmedullary Thyroid Carcinoma: A Retrospective Analysis of 117 Families.
Zhang YB; Wang XX; Zhang XW; Li ZJ; Liu J; Xu ZG; Tang PZ
Chin Med J (Engl); 2018 Feb; 131(4):395-401. PubMed ID: 29451143
[TBL] [Abstract][Full Text] [Related]
33. [Next generation sequencing technology for susceptible gene screening in familial non-medullary thyroid carcinoma].
Dong L; Yu Y; Yu JP; Hao WJ; Zheng XQ; Cheng YN; Han L; Zhao JZ; Gao M
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):24-28. PubMed ID: 28104029
[No Abstract] [Full Text] [Related]
34. [Clinical features of 17 patients with familial non medullary thyroid carcinoma].
Mosso L; Velasco S; Salazar I; Solar A; González H; Cardona B; Fardella C; González G; López JM; Rodríguez JA; Cruz F; Arteaga E
Rev Med Chil; 2007 Jun; 135(6):718-24. PubMed ID: 17728897
[TBL] [Abstract][Full Text] [Related]
35. Clinical Analysis of Familial Nonmedullary Thyroid Carcinoma.
Zhang Q; Yang S; Meng XY; Chen G; Pang RZ
World J Surg; 2016 Mar; 40(3):570-3. PubMed ID: 26711636
[TBL] [Abstract][Full Text] [Related]
36. [Clinical features of familial non-medullary thyroid cancer patients].
Zhang X; An C; Wan H; Zhang Z; Liu W; Li Z; Xu Z; Tang P
Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):69-73. PubMed ID: 24685091
[TBL] [Abstract][Full Text] [Related]
37. Should Total Thyroidectomy Be Recommended for Patients with Familial Non-medullary Thyroid Cancer?
Kim YS; Seo M; Park SH; Ju SY; Kim ES
World J Surg; 2020 Sep; 44(9):3022-3027. PubMed ID: 32556933
[TBL] [Abstract][Full Text] [Related]
38. FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility.
Tomaz RA; Sousa I; Silva JG; Santos C; Teixeira MR; Leite V; Cavaco BM
Clin Endocrinol (Oxf); 2012 Dec; 77(6):926-33. PubMed ID: 22882326
[TBL] [Abstract][Full Text] [Related]
39. Familial non-medullary thyroid cancer: a matched-case control study.
Maxwell EL; Hall FT; Freeman JL
Laryngoscope; 2004 Dec; 114(12):2182-6. PubMed ID: 15564841
[TBL] [Abstract][Full Text] [Related]
40. Is Familial Nonmedullary Thyroid Cancer A More Aggressive Type of Thyroid Cancer?
Muallem Kalmovich L; Jabarin B; Koren S; Or K; Marcus E; Tkacheva I; Benbassat C; Steinschneider M
Laryngoscope; 2021 Feb; 131(2):E677-E681. PubMed ID: 32761812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]